August 2018
Updated Laboratory Test Requisition Procedure

Effective August 27, 2018, Redwood Toxicology Laboratory is updating its laboratory requisition procedure. Under the new procedure, if your agency submits specimens for clinical drug testing, you must indicate so on the requisition form.

A drug test is clinical if the test result(s) will be used for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings. This includes if the test result(s) will be used for referring, offering, or making available treatment to a test subject.

If your agency requests drug testing that does not meet the above definition of a clinical test, you should indicate "No" during the ToxAccess collection when prompted with the question, "Is This a Clinical Test?" Agencies requesting non-clinical testing using a hand-written label or form should continue to use the current process. However, in anticipation of future changes to the paper requisition process, we encourage you to contact your sales representative to set up specimen collection using ToxAccess.

If your agency requests clinical drug testing and uses ToxAccess for test requisitioning, you will need to indicate that the drug test is clinical during the "Collect Specimen" process and identify the ordering practitioner. You will also be required to choose the tests to be performed on the specimen. Routine tests will no longer be checked by default. When you print the requisition form, the ordering practitioner's information will now appear on the form.

You will also need to provide information about your ordering practitioner(s) in ToxAccess prior to requisitioning clinical drug tests. From the "Agency Administration" menu, select "Practitioners," and then select "New Practitioner" to create a new ordering practitioner. For each ordering practitioner for your agency, you will need to specify the ordering practitioner's name, National Provider Identifier (NPI), and contact information.

If your agency requests clinical drug testing and uses a hand-written label or form for test requisitioning, you will need to begin conducting such requisitions using ToxAccess in order to ensure that the information required for clinical drug testing is properly captured. Your sales representative can assist you in transitioning to ToxAccess.

Redwood Toxicology Laboratory is committed to maintaining the highest compliance standards in the drug testing industry. If you have any questions regarding this update, please contact your sales representative at 800.255.2159 option 1.

MKT51396 REV1 8/18

ToxAccess Training

Support and training resources are now available for the updated laboratory requisition process. Details for webinar training and Q&A sessions can be found below.

Join Webex Conference
Use the Webex information below to join all training sessions.
https://inverness.webex.com/join/Greg.Paulis | 597 938 882
Toll Free Phone: 1-800-391-9177
Conference Code: 198 535 7385

Training Option 1

If your agency requests clinical drug testing and uses ToxAccess for test requisitioning and you need training on how to perform a specimen collection for a clinical drug test request using the updated process, join the training sessions below.

August 21st through August 31st
All times are EST
Monday: 7:00AM, 8:30AM, and 4:30PM
Tuesday: 11:30AM, 4:30PM
Wednesday: 7:00AM, 8:30AM, 4:30PM
Thursday: 11:30AM, 4:30PM
Friday: 7:00AM, 11:00AM, 1:00PM

Training Option 2

If your agency requests clinical drug testing and uses a hand-written label or form for test requisitioning and you need training on using ToxAccess for clinical drug test requisitions, please join the following training sessions.

August 21st through August 31st
All times are EST
Monday: 11:00AM
Tuesday: 1:30PM
Wednesday: 11:00AM
Thursday: 1:30PM
Friday: 9:00AM